[1]
E. Burle, J. Mazereeuw-Hautier, and M. Severino-Freire, “Reconsidering Efficacy and Safety: A Critical Appraisal of Repurposing Anti-inflammatory Targeted Drugs in Darier disease”, Acta Derm Venereol, vol. 106, pp. adv–2026, Apr. 2026.